We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 822

Parametritis: inventive step - Euroceltique S.A. v Sandoz Pty Ltd

  • Herbert Smith Freehills LLP
  • -
  • Australia
  • -
  • November 20 2009

This decision of the Australian Patent Office (Office) is of interest to the extent that it outlines the approach that the Office will take in considering the validity of a claim limited by reference to specified parameters

Patents Court judgment in Ratiopharm GmbH and Sandoz Limited v Napp Pharmaceutical Holdings Limited

  • Bird & Bird
  • -
  • United Kingdom
  • -
  • March 11 2009

The Patents Court (Mr Justice Floyd) handed judgment down on 16 December 2008 relating to two patents regarding formulations to achieve slow release of the opioid pain killing drug, oxycodone

Federal Court holds PM(NOC) findings not necessarily irrelevant in subsequent patent actions VIAGRA (sildenafil citrate)

  • Norton Rose Fulbright Canada LLP
  • -
  • Canada
  • -
  • June 16 2010

On June 11, 2010, Prothonotary Aalto of the Federal Court dismissed a motion by Apotex seeking to strike allegations of res judicata, issue estoppel, collateral estoppel, comity and abuse of process (the “Abuse Allegations”) from Pfizer’s Statement of Defence in an impeachment action

Apotex v Sanofi, case management directions on the late disclosure of documents or information

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

Prior to a case management conference within a streamlined case, the Prothonotary ordered the parties to make submissions at the conference on the question of whether a date should be set after which the parties required either consent of the other party or leave of the Court to serve a supplementary affidavit of documents or a corrected or completed information in answer to a discovery question

Apotex v AstraZeneca; motion to strike parts of a statement of claim in a Section 8 proceeding

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • August 15 2007

The Court dismissed the appeal of a Prothonotary's decision refusing to strike parts of the Statement of Claim

REVATIO patent ruled invalid for lack of sound prediction and obviousness

  • Stikeman Elliott LLP
  • -
  • Canada
  • -
  • June 18 2010

In an application under the Patented Medicines (Notice of Compliance) Regulations (“Regulations”), Pfizer sought an order prohibiting the Minister of Health (“Minister”) from issuing a notice of compliance (“NOC”) to Ratiopharm for a generic version of the drug REVATIO (containing the medicine sildenafil citrate (“sildenafil”) the same medicinal ingredient contained in VIAGRA) until after the expiry of the 324 patent

Pharmaceutical trademarks

  • Bereskin & Parr LLP
  • -
  • Canada
  • -
  • August 30 2009

Many trademark challenges are specific to the pharmaceutical industry

Patentees score a victory in the Supreme Court of Canada: validity of selection patents upheld

  • McCarthy Tétrault LLP
  • -
  • Canada
  • -
  • November 7 2008

On Thursday, November 6, 2008, the Supreme Court of Canada released its much-anticipated decision in Sanofi-Synthelabo Canada Inc. v. Apotex Inc

PMPRB to require reporting of payments to third parties

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • August 21 2008

In separate announcements issued this week, the Patented Medicine Prices Review Board (PMPRB) has ended months of consultation and speculation by announcing that it will implement a policy change, first reported in its April 2007 NEWSletter, to require that patentees report all rebates and discounts, including payments made to third parties, in their filings on the prices of patented medicines

AstraZeneca v. Apotex; interlocutory motion for reply evidence; esomeprazole

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • February 12 2010

The Court dismissed AstraZeneca's appeal from the order of a prothonotary refusing to strike parts of Apotex' evidence and refusing to permit the applicants to file reply